FTL
Ferritin light chain
Also known as: FRIL_HUMAN, MGC71996, NBIA3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02792
- Gene
- FTL
- Ensembl
- ENSG00000087086
- Chromosome
- 19
- Canonical length
- 175 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes the light subunit of the ferritin protein. Ferritin is the major intracellular iron storage protein in prokaryotes and eukaryotes. It is composed of 24 subunits of the heavy and light ferritin chains. Variation in ferritin subunit composition may affect the rates of iron uptake and release in different tissues. A major function of ferritin is the storage of iron in a soluble and nontoxic state. Defects in this light chain ferritin gene are associated with several neurodegenerative diseases and hyperferritinemia-cataract syndrome. This gene has multiple pseudogenes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
175 residues, UniProt reviewed canonical sequence.
>P02792|FTL
1 MSSQIRQNYS TDVEAAVNSL VNLYLQASYT YLSLGFYFDR DDVALEGVSH FFRELAEEKR
61 EGYERLLKMQ NQRGGRALFQ DIKKPAEDEW GKTPDAMKAA MALEKKLNQA LLDLHALGSA
121 RTDPHLCDFL ETHFLDEEVK LIKKMGDHLT NLHRLGGPEA GLGEYLFERL TLKHDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FTL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 14,258 nTPM
Expression across tissuesHPA
Tissue
- liver: 14,258 nTPM
- kidney: 8,893 nTPM
- lung: 7,141 nTPM
- spleen: 6,658 nTPM
- adipose tissue: 6,633 nTPM
- spinal cord: 6,360 nTPM
Single-cell type
- kupffer cells: 144,497 nCPM
- hofbauer cells: 84,950 nCPM
- hepatocytes: 26,483 nCPM
- macrophages: 21,759 nCPM
- enterocytes: 19,706 nCPM
- monocytes: 19,371 nCPM
Immune cell
- neutrophil: 125,829 nTPM
- intermediate monocyte: 102,247 nTPM
- total PBMC: 94,170 nTPM
- non-classical monocyte: 91,838 nTPM
- eosinophil: 77,559 nTPM
- classical monocyte: 71,231 nTPM
Brain region
- thalamus: 4,038 nTPM
- white matter: 3,409 nTPM
- medulla oblongata: 3,333 nTPM
- pons: 3,302 nTPM
- spinal cord: 3,150 nTPM
- basal ganglia: 3,096 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FTL.
Disease | AllUniProt
Conditions FTL is implicated in, by any mechanism.
- Hyperferritinemia with or without cataract (HRFTC) MIM:600886
- Neurodegeneration with brain iron accumulation 3 (NBIA3) MIM:606159
- L-ferritin deficiency (LFTD) MIM:615604
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 245 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary hyperferritinemia with congenital cataracts
- Neuroferritinopathy
- L-ferritin deficiency
- FTL-related disorder
- Iron metabolism disorders
Disease | ImmuneIEDB
Conditions an epitope on FTL was assayed in.
- autoimmune disease of blood B and T cell
ReferencesPubMed · IEDB
Publications for FTL from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Antibodies specific to ferritin light chain polypeptide are frequently detected in patients with immune‑related pancytopenia.
2020 · Mol Med Rep · RCR 0.3 · 5 citations - Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer.
2022 · J Hepatocell Carcinoma · RCR 0.2 · 2 citations
Reference: B cellIEDB
1 publication
- Ferritin Light Chain: A Candidate Autoantigen in Immuno-Related Pancytopenia.
2022 · Front Immunol · RCR 0.3 · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.44
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FTL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FTL as an antibody target. Whether an autoantibody or antibody against FTL could matter depends on whether native FTL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FTL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FTL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...